Latest News from Barts Cancer Institute
Catch up with science, news and features from across the institute

DNA-copying overload may reveal which cancer cells respond to ATR-inhibitor drugs
Researchers have uncovered a mechanism that makes some cancer cells especially vulnerable to experimental drugs known as ATR inhibitors. The findings could support the development of tests to identify the patients most likely to benefit.
Publications · 17 August 2026


Our Research
Barts Cancer Institute is internationally renowned in multiple areas of cancer research. Our strength lies in our culture of close, multidisciplinary collaboration among our more than 350 research staff and 100 graduate students, based across 7 scientific centres and units:
- Biomarkers & Biotherapeutics
- Cancer Cell & Molecular Biology
- Cancer Evolution
- Haemato-oncology
- Tumour Biology
- Tumour Microenvironment
- Experimental Cancer Medicine
Explore the Institute
Learn how you could help drive cancer discoveries by working with us, studying with us, or engaging with us.

Latest Job Vacancies
Explore our current job openings at BCI and find the right opportunity for you.

Study with Us
Launch your career in cancer research with our postgraduate maters, diploma and doctorate programmes.

Public Engagement
Learn how we're sharing our knowledge and collaborating closely with patients and the public.







